Inhalant Anesthetics – BCSE Study Guide

Overview and Clinical Importance

Inhalant anesthetics are the cornerstone of veterinary general anesthesia, providing reliable, titratable, and reversible unconsciousness for surgical and diagnostic procedures. Understanding the pharmacology of isoflurane and sevoflurane, including their minimum alveolar concentration (MAC) values, factors affecting anesthetic requirements, vaporizer function, and breathing circuit selection, is essential for safe anesthetic management across all veterinary species.

Clinically, proper use of inhalant anesthetics directly impacts patient safety, recovery quality, and surgical outcomes. The ability to rapidly adjust anesthetic depth, combined with minimal metabolism and rapid elimination, makes these agents ideal for procedures of varying duration and complexity.

Isoflurane

Chemical Properties and Pharmacology

Isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl ether) is a halogenated ether inhalant anesthetic that has been the workhorse of veterinary anesthesia since the 1980s. It is a clear, colorless liquid with a pungent, ethereal odor that some patients find irritating during mask or chamber induction.

Key Physical Properties:

MEMORY AID - Isoflurane Blood:Gas: "ISO has 1.4" - Isoflurane blood:gas coefficient is 1.4. This is higher than sevoflurane (0.65), meaning isoflurane is MORE soluble in blood and therefore has SLOWER induction and recovery compared to sevoflurane.

Mechanism of Action

Isoflurane produces anesthesia through multiple mechanisms at the cellular level. The primary site of action for immobility (MAC) is the spinal cord, while unconsciousness and amnesia are mediated through effects on the brain. Key mechanisms include:

Enhancement of inhibitory neurotransmission: Isoflurane potentiates GABA-A receptor activity, increasing chloride conductance and hyperpolarizing neurons. It also enhances glycine receptor function in the spinal cord.

Inhibition of excitatory neurotransmission: Isoflurane inhibits NMDA-type glutamate receptors and nicotinic acetylcholine receptors, reducing excitatory transmission.

Ion channel effects: Isoflurane activates two-pore-domain potassium channels (TREK-1, TASK), causing membrane hyperpolarization and reduced neuronal excitability.

Cardiovascular Effects

Isoflurane causes dose-dependent cardiovascular depression through direct myocardial depression and vasodilation. At clinically relevant concentrations (1.0-1.5 MAC):

Blood pressure decreases primarily due to peripheral vasodilation rather than decreased cardiac output. Heart rate may increase slightly due to baroreflex activation. Cardiac output is generally maintained better than with some other agents. Coronary vasodilation occurs, which historically raised concerns about "coronary steal" (now considered clinically insignificant).

Respiratory Effects

Isoflurane causes dose-dependent respiratory depression with decreased tidal volume and respiratory rate. It depresses the ventilatory response to hypercapnia and hypoxia. Isoflurane is a bronchodilator and does not sensitize the myocardium to catecholamine-induced arrhythmias (unlike halothane).

MEMORY AID - Isoflurane Respiratory: "ISO Irritates, ISO Dilates" - Isoflurane is IRRITATING to airways (pungent) making mask induction difficult, but paradoxically causes BRONCHODILATION which can be beneficial in patients with reactive airway disease.

Clinical Advantages of Isoflurane

Lower cost compared to sevoflurane (approximately $0.10/mL vs $0.80/mL). Excellent stability with CO2 absorbents. Minimal metabolism (less than 0.25%), reducing concerns for hepatotoxicity or nephrotoxicity. Well-established safety profile with decades of clinical use. Maintains cardiac output better than some alternatives.

Sevoflurane

Chemical Properties and Pharmacology

Sevoflurane (fluoromethyl 2,2,2-trifluoro-1-[trifluoromethyl]ethyl ether) is a fluorinated methyl isopropyl ether that offers some advantages over isoflurane, particularly for induction. It has a less pungent odor, making mask and chamber inductions smoother and less stressful for patients.

Key Physical Properties:

MEMORY AID - Sevoflurane Speed: "SEVO is SWIFT" - Sevoflurane has a LOW blood:gas partition coefficient (0.65), meaning it reaches equilibrium faster. This translates to FASTER induction and FASTER recovery. Remember: LOW solubility = FAST kinetics.

Compound A and CO2 Absorbent Interaction

Sevoflurane reacts with CO2 absorbents, particularly when they are dry or contain strong bases (like barium hydroxide lime), to produce Compound A (fluoromethyl-2,2-difluoro-1-[trifluoromethyl]vinyl ether). Compound A has been shown to be nephrotoxic in rats at high concentrations, but clinical significance in veterinary patients remains unclear.

To minimize Compound A production: Use fresh gas flows greater than 2 L/min. Use CO2 absorbents containing calcium hydroxide rather than barium hydroxide. Do not allow CO2 absorbent to dry out completely. Replace absorbent regularly.

Clinical Advantages of Sevoflurane

Non-pungent odor allows smooth mask and chamber inductions. Faster induction and recovery due to lower blood:gas solubility. Minimal airway irritation. Less cardiovascular depression at equipotent doses compared to isoflurane. Particularly useful for: Mask inductions in fractious or fearful patients. Exotic species requiring chamber induction. Procedures requiring rapid recovery. Patients with hepatic dysfunction (though higher metabolism than isoflurane, metabolites are inorganic fluoride).

Isoflurane vs. Sevoflurane: Side-by-Side Comparison

MEMORY AID - ISO vs SEVO: "ISO is STABLE and SLOW, SEVO is SWEET and SWIFT" - Isoflurane is more stable with absorbents and has slower kinetics. Sevoflurane smells sweeter (non-pungent) and has swifter induction/recovery.

Minimum Alveolar Concentration (MAC)

Definition and Concept

Minimum Alveolar Concentration (MAC) is defined as the minimum alveolar concentration of an inhaled anesthetic at 1 atmosphere that prevents movement in response to a supramaximal noxious stimulus (typically surgical incision or tail/toe clamping) in 50% of subjects. MAC is the gold standard measure of inhalant anesthetic potency.

Key concepts to understand about MAC:

MAC represents an ED50: 50% of patients will not move at 1 MAC. To prevent movement in 95% of patients (ED95), approximately 1.2-1.3 MAC is required.

MAC reflects partial pressure, not concentration: At equilibrium, the partial pressure of anesthetic in the alveolus equals the partial pressure in the blood and brain. This is why alveolar concentration correlates with brain concentration.

MAC is additive: When multiple inhalants are used together, their MAC fractions add up (0.5 MAC isoflurane + 0.5 MAC sevoflurane = 1 MAC total).

Lower MAC = Higher potency: An agent with MAC of 1% is more potent than one with MAC of 2% because less is needed to produce the same effect.

MAC Variants

Several variants of MAC have been defined for specific clinical purposes:

MEMORY AID - MAC Multiples: "MAC Attack Ladder" - Think of climbing a ladder of anesthetic depth: 0.3 MAC (awake), 1.0 MAC (surgical - 50%), 1.3 MAC (intubation/95% surgical), 1.5-1.7 MAC (BAR - blocks BP/HR changes). Higher concentrations = deeper anesthesia.

Species-Specific MAC Values

MAC values vary by species and must be memorized for the BCSE. The following table presents clinically relevant MAC values:

MEMORY AID - Species MAC Pattern: "Cats are Contrary" - Cats typically have the HIGHEST MAC values among domestic species (1.6-1.7% for isoflurane). Dogs are in the middle (1.3%). Ruminants often have lower MAC values. Remember the sevoflurane MAC pattern: it is approximately 1.7-1.8 times the isoflurane MAC for most species.

Factors Affecting MAC

Understanding factors that alter MAC is crucial for safe anesthetic management and is heavily tested on the BCSE. These factors can be categorized into those that increase MAC (patient requires MORE anesthetic), those that decrease MAC (patient requires LESS anesthetic), and those that have no significant effect.

Factors That DECREASE MAC (Patient Needs LESS Anesthetic)

MEMORY AID - Factors That DECREASE MAC: "HAPPY OLD PREGNANT CATS" - Hypothermia, Alpha-2 agonists, Pregnancy, PaCO2 elevated, Young age (neonates), Opioids, Lidocaine (IV), Depressants (CNS), Acepromazine, Trough blood pressure, Shock. These all DECREASE MAC.

Factors That INCREASE MAC (Patient Needs MORE Anesthetic)

MEMORY AID - Factors That INCREASE MAC: "HYPER YOUNG FEVER" - HYPERthermia, HYPERthyroidism, HYPERnatremia, YOUNG age, FEVER all INCREASE MAC. Also stimulants (amphetamines, cocaine, MAOIs) and chronic alcohol abuse increase MAC.

Factors That DO NOT Affect MAC

Importantly, several factors are commonly misconceived to affect MAC but actually have minimal or no effect:

Sex/Gender: Male and female patients have similar MAC values. Duration of anesthesia: MAC remains constant regardless of how long anesthesia has been maintained. PaCO2 (10-90 mmHg): Moderate changes in carbon dioxide do not affect MAC. PaO2 (40-500 mmHg): Moderate changes in oxygen tension do not affect MAC. Metabolic alkalosis or acidosis: Only severe metabolic derangements alter MAC. Hypertension: High blood pressure does not increase MAC. Moderate anemia: Mild to moderate anemia does not significantly alter MAC.

Vaporizer Function

Precision Vaporizer Design

Precision vaporizers (also called "variable bypass," "concentration-calibrated," or "out-of-circuit" vaporizers) are the standard for delivering inhalant anesthetics in veterinary practice. These agent-specific devices convert liquid anesthetic into a precise concentration of vapor mixed with carrier gas (oxygen).

The fundamental principle of precision vaporizer function is the controlled mixing of saturated anesthetic vapor with fresh gas to achieve a specific output concentration. Because saturated vapor concentrations are dangerously high (31% for isoflurane, 21% for sevoflurane), the vaporizer must precisely dilute this vapor to clinically useful concentrations (0-5% for isoflurane, 0-8% for sevoflurane).

Variable Bypass Mechanism

Modern precision vaporizers use a variable bypass design with two chambers:

1. Vaporizing Chamber: A portion of fresh gas flow enters this chamber containing liquid anesthetic and wicks. The gas becomes fully saturated with anesthetic vapor at the agent-specific saturated vapor concentration.

2. Bypass Chamber: The remaining fresh gas flow bypasses the vaporizing chamber entirely, containing no anesthetic.

The vaporizer dial controls a valve that adjusts the ratio of gas flowing through each chamber. When the two flows rejoin at the common gas outlet, the final concentration matches the dial setting.

Compensation Mechanisms

Precision vaporizers incorporate several compensation mechanisms to maintain accurate output:

Temperature Compensation: Vapor pressure is temperature-dependent - as temperature increases, more liquid vaporizes. A bimetallic strip or expansion element automatically adjusts the bypass ratio to maintain constant output despite temperature fluctuations.

Flow Compensation: Vaporizers are designed to maintain accurate output across a range of fresh gas flows, typically 0.2-10 L/min. At very low flows (less than 200 mL/min) or very high flows (greater than 10 L/min), accuracy may decrease.

Pressure Compensation: The pumping effect from positive pressure ventilation can force gas back into the vaporizer, potentially causing concentration spikes. Check valves prevent this backflow.

Agent Specificity

The agent specificity of vaporizers is determined by: Calibration for the specific vapor pressure of the agent. Design of wicks and baffles for the agent's physical properties. Dial markings corresponding to the agent's clinically useful range. Color coding (purple for isoflurane, yellow for sevoflurane).

MEMORY AID - Vaporizer Color Coding: "I See Purple" - Isoflurane vaporizers are PURPLE. Sevoflurane vaporizers are YELLOW. Never mix agents! Purple = Potent smell (Isoflurane is more pungent). Yellow = Youthful/fast (Sevoflurane has faster kinetics).

Vaporizer Maintenance and Safety

Proper vaporizer maintenance ensures accurate delivery and patient safety:

Annual calibration verification by qualified technicians. Keep vaporizer upright during transport (tilting can flood bypass chamber with liquid). Fill only when vaporizer dial is in OFF position. Do not overfill past maximum fill line. Use only the agent for which the vaporizer is calibrated. Allow warm-up time if recently transported or very cold.

Breathing Circuits

Breathing circuits deliver anesthetic gases to the patient and remove exhaled carbon dioxide. The two main categories are rebreathing (circle) systems and non-rebreathing systems. Selection depends on patient size, procedure duration, and clinical circumstances.

Rebreathing (Circle) Systems

Rebreathing systems (circle systems) allow exhaled gases to be recycled after carbon dioxide removal by a chemical absorbent (soda lime or calcium hydroxide lime). These are the most commonly used circuits in veterinary anesthesia for patients greater than 5-7 kg.

Components of Circle Systems

Fresh Gas Flow Rates for Circle Systems

Fresh gas flow requirements vary based on whether the circuit is used as closed, low-flow, or semi-closed:

Advantages and Disadvantages of Circle Systems

Advantages: Economical (recycled gases reduce cost). Conservation of heat and humidity. Reduced environmental pollution. Can be used for prolonged procedures. Versatile for various patient sizes greater than 5 kg.

Disadvantages: Higher resistance to breathing (one-way valves, absorbent). Greater mechanical dead space. Slower response to vaporizer changes (large circuit volume). Requires functioning CO2 absorbent. More complex with more potential failure points.

MEMORY AID - Circle System Advantages: "CHEW" - Conservation of heat, Humidity preserved, Economical gas use, Wide range of patient sizes (greater than 5 kg). Circle systems are economical for longer cases.

Non-Rebreathing Systems

Non-rebreathing (NRB) systems prevent rebreathing of exhaled gases by using high fresh gas flows to flush CO2-laden gas from the circuit rather than using chemical absorption. Common NRB circuits include the Bain coaxial circuit and the Jackson-Rees (modified Ayre's T-piece) circuit.

Bain Coaxial Circuit

The Bain circuit is a coaxial design where fresh gas flows through a narrow inner tube to the patient end, while expired gas returns through the larger outer tube. This design provides some warming of inspired gas and compact patient connection.

Fresh gas flow requirement: 150-200 mL/kg/min (2.5-3x minute ventilation) to prevent CO2 rebreathing.

Jackson-Rees Circuit

The Jackson-Rees circuit (modified Ayre's T-piece) features a T-connector at the patient end with fresh gas inlet, a reservoir bag, and an adjustable valve for scavenging. It is commonly used for very small patients and provides excellent control for manual ventilation.

Fresh gas flow requirement: 200-300 mL/kg/min (3-5x minute ventilation) to prevent CO2 rebreathing.

Advantages and Disadvantages of NRB Systems

Advantages: Low resistance to breathing (ideal for small patients). Minimal mechanical dead space. Rapid response to vaporizer changes. Lightweight and simple. No CO2 absorbent required.

Disadvantages: High fresh gas flow requirements (expensive). Greater waste anesthetic gas production. Patient cooling and airway drying from high flows. Not economical for prolonged procedures. Limited to smaller patients.

Circuit Selection Summary

MEMORY AID - NRB Flow Rates: "Bain = 200, JR = 300" - Bain circuit requires 200 mL/kg/min minimum fresh gas flow. Jackson-Rees requires 200-300 mL/kg/min. These HIGH flows are needed to prevent CO2 rebreathing since there is no absorbent.